Novartis Gene Therapies, Inc. et al. vs. Genzyme Corporation et al.

Explore the PTAB proceeding IPR2023-01044 filed by Novartis Gene Therapies, Inc. et al. on 2023-06-30. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-01044

Filing Date

2023-06-30

Accorded Filing Date

2023-06-30

Institution Decision Date

2024-01-09

Last Modified Date

2024-03-04

Proceeding Type

IPR

Termination Date

2024-03-04

Trial Status

Terminated-Settled

Parties & Counsel

Petitioner

Novartis Gene Therapies, Inc. et al.

Represented By

Livingstone, Johnet al

Patent Owner / Respondent

Genzyme Corporation et al.

Represented By

Antons, Amandaet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 15544498

Respondent Patent Number 10429288

External Links

Espacenet

Google Patents

Respondent Inventor Catherine R. O'RIORDAN et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

40 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name LISA P. RASMUSSEN - SANOFI

Customer Number 5487

Address 450 WATER STREET, Cambridge, MA, 02141, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
36844	Joseph Kirk Jr	908-981-6911
39150	John Conway	908-981-6688
40564	Anne Collins	978-341-0036
44045	Sandra Brockman-Lee	857-523-9199
45736	Pamela Torpey	508--27-1-0683
45979	Milan Vinnola	619-238-0062
47150	Nicole Parsons	617-685-5697
52610	Kelly Bender	2485930581
54154	Allyson Hatton	508-361-7392
54958	Janann Ali	617-685-5645
58163	Alejandro Martinez	617-685-5935
59682	Jeremy Bond	617-685-5653
61358	Ryan Mcquade	617-838-5595
61393	Isaac Hubner	617-866-4544
62108	Siew Chong	973-980-0397
63001	Stephanie Donahue	908-331-4406
63750	Mayssam Ali	617-685-5646
64259	Xuemei Peng	908-981-6951
64740	Alan Townsley	202-857-2278
64828	Jeffrey Weber	617-685-6431
66863	Patricia Callanan	617-866-4404
67265	Yi Wang	617-685-5735
67340	Dhruv Kaushal	617-245-4065
68308	Jonathan Andron	617-685-5658
68315	Meenakshy Chakravorty	781-418-9211
69032	Robert Bolcome Iii	857-331-1597
69052	Jing Wang	617-951-8720
69953	Janet Tse	617-564-6571
70740	Erika Wallace	617-937-1397
71226	Meghan Klaric	313-465-7211
72110	Daniel Tate	800-981-2491
72475	Indrani Dasgupta	617-685-5977
72868	David Lefebvre	617-685-5338
72919	Ted Ririe	385-312-6536
74124	Evan King	781-234-4286
75427	Shirley Tan	617-646-8444
77001	Sara Haines	003-348-1492783
80264	Christopher Marion	314-517-7022
80424	Victoria Pedanou	508-736-4409
81386	Erin May	617-251-9709

Proceeding Documents

Termination Decision: Post-DI Settlement TERMINATE

2024-03-04 FILING PARTY: BOARD

Download

Joint Request That Settlement Agreement Be Treated As Business Confidential Information And Kept Separate MOTION

2024-02-26 FILING PARTY: PETITIONER

Download

Petitioners' Updated Exhibit List NOTICE

2024-02-26 FILING PARTY: PETITIONER

Download

Joint Motion to Terminate MOTION

2024-02-26 FILING PARTY: PETITIONER

Download

Order: Authorizing the Filing of a Joint Motion to Terminate - 35 USC 317;,37 CFR 42.20(b), 42.72 ORDER

2024-02-21 FILING PARTY: BOARD

Download

Novartis Gene Therapies, Inc. et al. vs. Genzyme Corporation et al.

Proceeding Overview

Parties & Counsel

Petitioner

Novartis Gene Therapies, Inc. et al.

Represented By

Patent Owner / Respondent

Genzyme Corporation et al.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Termination Decision: Post-DI Settlement TERMINATE

Joint Request That Settlement Agreement Be Treated As Business Confidential Information And Kept Separate MOTION

Petitioners' Updated Exhibit List NOTICE

Joint Motion to Terminate MOTION

Order: Authorizing the Filing of a Joint Motion to Terminate - 35 USC 317;,37 CFR 42.20(b), 42.72 ORDER

Ex. 3101 Exhibit

Order Granting Request for Withdrawal of Director Review of Institution Decision REQUEST

Petitioners' Objections to Patent Owner's Evidence OTHER

Ex. 3100 Exhibit

PATENT OWNER’S OBJECTIONS TO EVIDENCE FILED WITH THE PETITION OTHER

Patent Owner's Request for Rehearing by the Director REQUEST

Order: SCHEDULING ORDER ORDER

DECISION Granting Institution of Inter Partes Review 35 U.S.C. § 314, 37 C.F.R. § 42.4 DECISION

Patent Owner's Preliminary Response POPR

Sommer (2003) Exhibit

Declaration of Jeffrey C. Hansen Exhibit

Spies (2020) Exhibit

Matsushita (2008) Exhibit

Burnham (2015) Exhibit

Wright (2014) Exhibit

Xie (2002) Exhibit

Collaud (2018) Exhibit

Hansen CV Exhibit

Notice : Mandatory Notice NOTICE

Notice: Notice filing date accorded NOTICE

Notice : Power of Attorney NOTICE

Third Party Observation for Application Number EP20160703205 Exhibit

Petition for Inter Partes Review PETITION

Berkowitz 2007 Exhibit

Introduction to Analytical Ultracentrifugation Exhibit

Berkowitz 2015 Exhibit

US 2009/0017542 A1 Exhibit

WO 2014/125101 A1 Exhibit

288 File History Exhibit

Zhao 2013 Exhibit

Petitioner's Supplemental Paper and Notice Ranking Petitions NOTICE

Glybera Assessment Report 2012 Exhibit

McCarty 2008 Exhibit

Petitioner Novartis Pharmaceuticals Corporation's Power of Attorney NOTICE

Hoque 1999 Exhibit

Cole 2008 Exhibit

Steinbach 1997 Exhibit

Gao 2014 Exhibit

Petitioner's Exhibit List NOTICE

Gombold 2006 Exhibit

US 10,429,288 Exhibit

Dafforn 2006 Exhibit

Petitioner Novartis Gene Therapies, Inc.'s Power of Attorney NOTICE

Schuck 2000 Exhibit

Cole 1999 Exhibit

Berkowitz Declaration Exhibit